Latest filing published 27 Mar 2026 for Knight Therapeutics Inc., €35k.
No signal scores available.
Luz Tatiana Urrea Franco discloses dealings in Knight Therapeutics Inc. to SEDI. We count 2 filings; the first trade dates from 1 August 2023 and the latest from 23 March 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 27 March 2026, the filings show an option exercise worth €35k in Knight Therapeutics Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations